Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

6,591 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Therapeutic efficacy of lenvatinib as third line treatment following regorafenib for unresectable hepatocellular carcinoma progression.
Hiraoka A, Kumada T, Hatanaka T, Tada T, Kariyama K, Tani J, Fukunishi S, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Kawata K, Yasuda S, Toyoda H, Chikara O, Tamai T, Kakizaki S, Tojima H, Nagashima T, Ueno T, Takizawa D, Naganuma A, Ohama H, Nouso K, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Koizumi Y, Nakamura S, Joko K, Michitaka K, Hiasa Y, Kudo M; Real-life Practice Experts for HCC (RELPEC) Study Group, HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan); GLSG (Gunma Liver Study Group). Hiraoka A, et al. Among authors: ishikawa t. Hepatol Res. 2021 Apr 10. doi: 10.1111/hepr.13644. Online ahead of print. Hepatol Res. 2021. PMID: 33837620
Surgically treated gastric cancer in Japan: 2011 annual report of the national clinical database gastric cancer registry.
Suzuki S, Takahashi A, Ishikawa T, Akazawa K, Katai H, Isobe Y, Miyashiro I, Ono H, Tanabe S, Fukagawa T, Muro K, Nunobe S, Kadowaki S, Suzuki H, Irino T, Usune S, Miyata H, Kakeji Y; Registration Committee of the Japanese Gastric Cancer Association. Suzuki S, et al. Among authors: ishikawa t. Gastric Cancer. 2021 Apr 3. doi: 10.1007/s10120-021-01178-5. Online ahead of print. Gastric Cancer. 2021. PMID: 33811588
6,591 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page